Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kneat.com Inc T.KSI

Alternate Symbol(s):  KSIOF

Healthcare Medical Devices
kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a... see more

Recent & Breaking News (TSX:KSI)

Kneat Achieves Record Results in Growth and Profitability

GlobeNewswire November 6, 2024

Global Medical Devices Manufacturer Selects Kneat to Digitize Validation

GlobeNewswire October 31, 2024

Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024

GlobeNewswire October 30, 2024

Kneat Announces Closing of $35.6 Million Bought Deal

GlobeNewswire October 10, 2024

Global Pharma Selects Kneat to Digitize Computer System Validation

GlobeNewswire October 8, 2024

Kneat Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus

GlobeNewswire October 7, 2024

Kneat Announces $35.0 Million Bought Deal Public Offering

Canada NewsWire September 23, 2024

Kneat Announces Record Revenue for Second Quarter 2024

GlobeNewswire August 6, 2024

Kneat and Körber Pharma Consulting Partner to Accelerate Life Sciences Digitalization 

GlobeNewswire June 26, 2024

Kneat Announces Results of Voting at Annual General Meeting

GlobeNewswire May 29, 2024

Kneat Announces Record Revenue for First Quarter 2024

GlobeNewswire May 8, 2024

Kneat to Announce 2024 First Quarter Financial Results May 8, 2024

GlobeNewswire May 1, 2024

Global Healthcare Leader Selects Kneat

GlobeNewswire February 28, 2024

Kneat Announces Record Revenue for Fourth Quarter and Full Year 2023

GlobeNewswire February 21, 2024

Kneat Announces Closing of $20 Million Bought Deal Including Full Exercise of Over-Allotment Option

GlobeNewswire February 14, 2024

Kneat to Announce 2023 Fourth-Quarter and Fiscal Year Financial Results February 21, 2024

GlobeNewswire February 13, 2024

Kneat Announces Upsize of the Previously Announced Bought Deal Public Offering to $17.4 Million

Canada NewsWire January 24, 2024

Kneat Announces $15.0 Million Bought Deal Public Offering

Canada NewsWire January 23, 2024

Global Consumer Products Company Selects Kneat

Canada NewsWire January 23, 2024

Kneat to Present at the Emerging Growth Conference on January 10, 2024

Canada NewsWire December 21, 2023